Back Bay Life Science Report

Back Bay Life Science Report

Por: Jonathan P. Gertler and Peter Bak
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
32 episodios disponibles

Latest episodes of the podcast Back Bay Life Science Report

Mostrando página 2 de 2

Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD 19/05/2022
The Evolving Regulatory Framework for Novel Medicines in the EU 25/04/2022
The Commercial Potential of Optogenetic Therapies 15/03/2022
The Latest on Antibiotic Development, Back Bay Life Science Advisors with Antabio 19/01/2022
Best Practices for Successful Sell-Side Licensing, Partnering and M&A 07/01/2022
Cell and Gene Therapy Investment Trends 22/11/2021
MedTech Investing with Paul LaViolette of SV Health Investors and Jonathan P. Gertler, MD, Back Bay Life Science Advisors and BioVentures Medtech Funds 13/10/2021
Remote Patient Monitoring 05/08/2021
New Drug Pricing and Market Access 30/06/2021
The Question of Investment in Antimicrobials 11/06/2021
Life Science SPACs: A Forward Look at this Evolving Asset Class 03/06/2021
Gene Therapies: What’s to Come as The Industry Moves Forward 02/06/2021
« Primera ‹ Anterior 1 2
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA